Voyageur Pharmaceuticals Ltd. (TSXV: VM) Stock Analysis & Fundamentals

VMVoyageur Pharmaceuticals Ltd.

TSXV · CA · Healthcare · Drug Manufacturers - Specialty & Generic · voyageurpharmaceuticals.ca

0.1600CAD-5.88%Mkt Cap: 21.57M $P/E: —7d ago

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, …

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap21.57M $

Enterprise Value26.08M $

Revenue (TTM)34.40K $

Gross Profit0 $

Net Income (TTM)-2.57M $

Revenue/Share0.0000 USD

Last Price0.1600 CAD

Fiscal Year EndNov 2025

MR QuarterMay 2026

Employees—

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-10.86

EV/Revenue758.09

P/S766.63

P/B40.00

EPS (TTM)-0.02

EPS (Forward)—

52W Range

0.070072% of range0.1950

52W High0.1950 CAD

52W Low0.0700 CAD

Profitability

Gross Margin0.00%

Oper. Margin-5312.69%

EBITDA Margin0.00%

Profit Margin-30231.56%

ROE-282.05%

ROA-113.77%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.11M $

CapEx (TTM)—

FCF Margin-811.73%

FCF Yield-1.29%

Net Debt-293.80K $

Net Debt/EBITDA0.12

Balance Sheet

Debt/Equity0.03

Current Ratio0.23

Quick Ratio0.18

Book Value/Sh0.0040 CAD

Cash/Share0.0020 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateMar 7, 2017

Splits

Last Split1:2

Split DateMar 7, 2017

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.179.48M

Float209.24M

Insiders6.93%

Institutions0.00%

Short Interest

Short Ratio1.0d

Short % Out.0.06%

Shares Short40.82K

Short (prev mo.)20.57K

Technical

SMA 500.1319 (+21.3%)

SMA 2000.1373 (+16.5%)

Beta0.29

S&P 52W Chg18.16%

Avg Vol (30d)188.48K

Avg Vol (10d)268.03K

Technical Indicators

RSI (14)61.6

MACD0.0099

MACD Signal0.0081

MACD Hist.+0.0018

BB Upper0.1720 CAD

BB Middle0.1455 CAD

BB Lower0.1190 CAD

BB Width36.48%

ATR (14)0.0084 CAD

Vol Ratio (20d)0.50x